In this video and audio edition of Ethics Talk, journal editor in chief, Dr Audiey Kao, talks with Dr Ziad Obermeyer about the potential impact on mortality of cost-sharing practices of health insurers.

Click here to read the transcript. 

Ziad Obermeyer, MD, MPhil is the Blue Cross of California Distinguished Associate Professor of Health Policy and Management, UC Berkeley School of Public Health.

Video

Recorded on March 9, 2021

 

Mar 2021

• Health determinants
• Disparities in health and health care/Social determinants
• Access to care/Cost barriers

Audio

 

Conflict of Interest Disclosure
Interviewee reports having equity stakes in Deep Health Dandelion Health and Berkeley Data Ventures as well as receiving speaking and consulting fees from Independence Blue Cross and Anthem.

Viewpoints expressed are those of interview participants and do not necessarily reflect the views and policies of the AMA.

Dec 2004

Cost and Clinical Practice Guidelines: Can Two Wrongs Make It Right?

Ellen K. Hummel, MD and Peter A. Ubel, MD

Jan 2002

Parity in Mental Health Coverage: Moral Hazard, Adverse Selection, and the Domenici/Wellstone Act

Sam Huber

Aug 2019

Ethics of Prescription Medication Access, Innovation, and Prescribing

Audiey C. Kao, MD, PhD

Header Image Issue Racial and Ethnic Health Equity in the US: Part 2 CME Off

In this video and audio edition of Ethics Talk, journal editor in chief, Dr Audiey Kao, talks with Dr Caleb Alexander about the US Food and Drug Administration's controversial decision to approve aducanumab for the treatment of Alzheimer's Disease.

Click here to read the transcript.

G. Caleb Alexander, MD, MS is professor of epidemiology and medicine at Johns Hopkins Bloomberg School of Public Health.

Video

Recorded on June 22, 2021

 

Jun 2021

• Clinical research
• Public health/Public policy intervention
• Access to care/Cost barriers
• High value care/Cost of care

Neurology Patient Care

Audio

 

Conflict of Interest Disclosure

Dr Alexander is past chair and current member of FDA's Peripheral and Central Nervous System Drugs Advisory Committee. He is a co-founding principal and equity holder in Monument Analytics, a health care consultancy whose clients include the life sciences industry as well as plaintiffs in opioid litigation. He was also a member of OptumRx's National Pharmacy and Therapeutics Committee.

Viewpoints expressed are those of interview participants and do not necessarily reflect the views and policies of the AMA.

Aug 2013

The Terminally Ill, Access to Investigational Drugs, and FDA Rules

Valarie Blake, JD, MA

Sep 2015

After Equipoise: Continuing Research to Gain FDA Approval

Allison Kerianne Crockett, MD

Jun 2012

Antidepressants and the FDA’s Black-Box Warning: Determining a Rational Public Policy in the Absence of Sufficient Evidence

Dien Ho, PhD

Header Image Issue Visibility and Measurability in Health Care Off

In this video and audio edition of Ethics Talk, journal editor in chief, Dr Audiey Kao, talks with Dr Donald Tomaskovic-Devey about the social and economic hurdles confronted by those among us in low-wage jobs during the COVID-19 pandemic.

Click here to read the transcript.

Donald Tomaskovic-Devey, PhD is the executive director of the Center for Employment Equity at University of Massachusetts Amherst.

Video

 

Jun 2020

• Ethics/Health policy
• Access to care/Rights
• Health policy/Health care as a right
• Justice/Human rights

Professionalism

Audio

 

Conflict of Interest Disclosure
Interviewee had no conflicts of interest to disclose.

Viewpoints expressed are those of interview participants and do not necessarily reflect the views and policies of the AMA.

Nov 2006

Socioeconomic Determinants of Health: The Facts Are In

Vanessa Yasmin Calderon

Jul 2015

The Distributional Effects of the Affordable Care Act’s Cadillac Tax by Worker Income

Bradley Herring, PhD and Erin Trish, PhD

Sep 2004

Medicine and Human Rights

Audiey Kao, MD, PhD

Header Image Issue Portraiture in Health Care CME Off